about
A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment.Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy.The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.Impaired renal function is related to deep and mixed, but not strictly lobar cerebral microbleeds in patients with ischaemic stroke and TIA.MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.Erratum to: Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy.Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat.Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysisEarly versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.Cognitive Impairment in Elderly Renal Inpatients: An Under-Identified PhenomenonEffect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIAEarly onset cerebral amyloid angiopathy following childhood exposure to cadaveric duraMinimally symptomatic cerebral amyloid angiopathy-related inflammation: three descriptive case reportsResponse by Banerjee et al to Letter Regarding Article, "Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy"Posterior circulation ischaemic strokeTotal MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic PopulationCerebrospinal Fluid Biomarkers in Cerebral Amyloid AngiopathyBaseline factors associated with early and late death in intracerebral haemorrhage survivorsRisks associated with oral deferiprone in the treatment of infratentorial superficial siderosisDomain-specific characterisation of early cognitive impairment following spontaneous intracerebral haemorrhageFeasibility of clinical trial recruitment for cerebral amyloid angiopathy: A specialist single centre experienceThe Role of Deferiprone in Iron ChelationPotential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIAThe impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysisLonger term stroke risk in intracerebral haemorrhage survivors
P50
Q34083364-C040162B-5453-464A-83FE-A81184617DFCQ35873757-E445BFA2-D801-4A06-80DE-DE8F51363706Q37730994-8783D149-FDB3-4D8B-896B-1E7FB5A807EEQ38636940-AF4CA79B-70FD-4470-B247-CEA16B9C5074Q39990911-57C48161-C5F8-46B6-AAF2-F6CC1ACBE559Q48248949-5FE23FF4-CBF9-4B81-9129-5BEA5316FA72Q48288663-A6F34D25-810C-4A11-8E0D-48075FB65DB1Q51980642-4975399D-13C7-4599-B0C2-16626A229737Q55369085-4EEAA63E-7263-4837-BB02-3658ECFD735EQ57167392-A9D35ABD-2188-4B89-A0D4-C7EFA055C4E3Q59391751-6E4610DD-A1E8-4B39-AAF6-5BD263487B42Q59647202-F9DB6B4D-2FB8-4004-A37B-66103C07B8FDQ64122132-E357F39E-77EA-493D-920C-563B0993D67EQ64237829-F4178F91-37B0-4C1D-BD0E-00AF03A9E9CEQ88043848-D3483DB3-7D16-43AF-94E2-6E1994A91F50Q88401095-7F734279-C434-4B7D-A8C0-C7531BEADFC1Q88413549-D061D862-9468-4A27-8009-5F4447175F61Q88907013-2DA775ED-16C4-4AE5-87A4-B88738DD6D23Q90356067-8692246A-6272-4F77-9AE9-1CB2E3BB069EQ90724519-93053FFF-B719-4B23-B7A8-8F16402F6095Q90761849-894B2687-4282-47E2-9BBE-8F8E1F41EA68Q90924924-9CCD740D-14C2-4EFE-8AFC-D9E3D0C90DB4Q91489654-739E0F73-D42E-4F16-B760-8E1D2FAEAF9BQ91968059-B6789E96-277F-4F30-9DF5-BF960FA3FC33Q92184705-6DBCFED2-394F-455F-9656-B12CB58D9B28Q93152608-0A0B600C-B9C4-4874-8EE1-76C467EBD55AQ96591510-E2921890-4A34-4FA7-A36C-DA7619E7B763
P50
description
researcher ORCID ID = 0000-0003-0190-7782
@en
wetenschapper
@nl
name
Gargi Banerjee
@ast
Gargi Banerjee
@en
Gargi Banerjee
@es
Gargi Banerjee
@nl
type
label
Gargi Banerjee
@ast
Gargi Banerjee
@en
Gargi Banerjee
@es
Gargi Banerjee
@nl
prefLabel
Gargi Banerjee
@ast
Gargi Banerjee
@en
Gargi Banerjee
@es
Gargi Banerjee
@nl
P106
P31
P496
0000-0003-0190-7782